Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Coles N Anthony
Relationship:  
City:   Cambridge
State:   MA
   
Insider Summary:
  
   
Companies Owned :   9    
Direct Shares   1,005,229    

Indirect Shares

   124,745      
Direct Value   $39,019,319    

Indirect Value

   $5,215,846      
Total Shares   1,129,974      
Total Value   $44,235,164      


Vertex Pharmaceuticals Inc $36,005,802 NPS Pharmaceuticals Inc $0 Laboratory Corp of America $544,165 Regeneron Pharmaceuticals Inc $1,401,177 Kineta Ord Shs $428,425 Cerevel Therapeutics Holdings, Inc. $639,751 Vertex Pharmaceuticals Inc $36,005,802 NPS Pharmaceuticals Inc $0 Laboratory Corp of America $544,165 Regeneron Pharmaceuticals Inc $1,401,177 Kineta Ord Shs $428,425 Cerevel Therapeutics Holdings, Inc. $639,751
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    1    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    1    
   
     Gain/Loss Ratio :
   0.0   
   -1.0   
     Percentage Gain/Loss :
     0.0%
 -2.1%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Vertex Pharmaceuticals Inc VRTX SVP, Comm. Ops. 2005-02-03 74,540 2005-02-03 2,076    Premium*  
            NPS Pharmaceuticals Inc NPSP President, COO & Direc... 2008-03-17 220,066 2007-01-31 0    Premium*  
            Onyx Pharmaceuticals Inc ONXX Chairman & CEO, Director 2013-10-01 0 2008-03-31 0    Premium*  
            Laboratory Corp of America LH Director 2013-02-15 2,584 2011-01-03 0    Premium*  
            Crispr Therapeutics Ag CRSP Director 2016-10-24 0 2016-10-24 70,000    Premium*  
            McKesson Corp MCK Director 2020-08-17 0 2018-07-25 0    Premium*  
            Regeneron Pharmaceuticals Inc REGN Director 2024-01-02 1,393 2019-01-02 0    Premium*  
            Kineta Ord Shs KA Executive Chair, Direc... 2021-02-01 691,008 2021-02-01 52,669    Premium*  
            Cerevel Therapeutics Holdings, I... CERE 2024-06-03 15,638 2022-12-09 0    Premium*  
* Premium Members only  

Records found :    117         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 2 of 5
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
ONXX Onyx Pharmaceuticals Inc President & CEO   •       •      –    2011-03-31 4 A $0.00 $0 D/D 65,000 114,796 0 -
ONXX Onyx Pharmaceuticals Inc President & CEO   •       •      –    2011-04-01 4 AS $35.02 $428,925 D/D (12,248) 102,548 0 -
LH Laboratory Corp of Americ... Director   –       •      –    2011-05-11 4 A $0.00 $0 D/D 700 1,000 0 -
ONXX Onyx Pharmaceuticals Inc President & CEO   •       •      –    2011-06-15 4 AS $36.10 $319,289 D/D (8,845) 93,733 0 -
LH Laboratory Corp of Americ... Director   –       •      –    2012-05-24 4 A $0.00 $0 D/D 1,800 2,800 0 -
ONXX Onyx Pharmaceuticals Inc President & CEO   •       •      –    2012-07-25 4 AS $73.97 $879,007 D/D (11,883) 162,853 0 -
ONXX Onyx Pharmaceuticals Inc President & CEO   •       •      –    2012-08-01 4 AS $74.37 $655,943 D/D (8,820) 154,033 0 -
ONXX Onyx Pharmaceuticals Inc President & CEO   •       •      –    2012-08-08 4 OE $29.03 $7,257,500 D/D 250,000 379,033 0 -
ONXX Onyx Pharmaceuticals Inc President & CEO   •       •      –    2012-08-08 4 S $72.18 $19,538,404 D/D (270,690) 108,343 0 -
ONXX Onyx Pharmaceuticals Inc President & CEO   •       •      –    2012-10-16 4 OE $29.03 $3,888,295 D/D 125,599 233,942 0 -
ONXX Onyx Pharmaceuticals Inc President & CEO   •       •      –    2012-10-16 4 AS $0.00 $0 D/D (125,599) 108,343 0 -
LH Laboratory Corp of Americ... Director   •       •      –    2013-02-15 4 GD $0.00 $0 D/D 216 2,584 0 -
ONXX Onyx Pharmaceuticals Inc Chairman & CEO   •       •      –    2013-03-28 4 OE $35.18 $384,799 D/D 10,938 119,392 0 -
ONXX Onyx Pharmaceuticals Inc Chairman & CEO   •       •      –    2013-03-28 4 AS $90.00 $984,420 D/D (10,938) 108,454 0 -
ONXX Onyx Pharmaceuticals Inc Chairman & CEO   •       •      –    2013-03-28 4 A $0.00 $0 D/D 26,800 135,254 0 -
ONXX Onyx Pharmaceuticals Inc Chairman & CEO   •       •      –    2013-04-01 4 AS $86.14 $1,001,722 D/D (11,629) 123,625 0 -
ONXX Onyx Pharmaceuticals Inc Chairman & CEO   •       •      –    2013-04-03 4 AS $89.30 $868,620 D/D (9,705) 113,920 0 -
ONXX Onyx Pharmaceuticals Inc Chairman & CEO   •       •      –    2013-04-03 4 OE $28.55 $499,899 D/D 17,278 131,198 0 -
ONXX Onyx Pharmaceuticals Inc Chairman & CEO   •       •      –    2013-06-05 4 OE $35.18 $230,851 D/D 6,562 137,760 0 -
ONXX Onyx Pharmaceuticals Inc Chairman & CEO   •       •      –    2013-06-05 4 AS $90.00 $590,580 D/D (6,562) 131,198 0 -
ONXX Onyx Pharmaceuticals Inc Chairman & CEO   •       •      –    2013-10-01 4 D $125.00 $3,204,000 D/D (25,632) 105,566 0 -
ONXX Onyx Pharmaceuticals Inc Chairman & CEO   •       •      –    2013-10-01 4 D $125.00 $13,195,750 D/D (105,566) 0 0 -
CRSP Crispr Therapeutics Ag Director   –       •      –    2016-10-24 4 A $14.00 $980,000 I/I 70,000 70,000 0 -
MCK McKesson Corp Director   –       •      –    2018-07-25 4 A $0.00 $0 D/D 1,350 1,350 0 -
MCK McKesson Corp Director   –       •      –    2018-08-31 4 AS $128.69 $173,732 D/D (1,350) 0 0 -
  117  Records found
  1   2  3   4   5      
  Page 2 of 5  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us